Seray Demir

1.5k total citations
9 papers, 282 citations indexed

About

Seray Demir is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Seray Demir has authored 9 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Seray Demir's work include Multiple Sclerosis Research Studies (4 papers), Nerve injury and regeneration (3 papers) and RNA Interference and Gene Delivery (2 papers). Seray Demir is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Nerve injury and regeneration (3 papers) and RNA Interference and Gene Delivery (2 papers). Seray Demir collaborates with scholars based in Germany, Switzerland and United States. Seray Demir's co-authors include Fred Lühder, Stefan Wiese, Niels Kruse, R. Gold, Ines Siglienti, Harald Neumann, Ellen Gerhardt, Ralf A. Linker, Michael Sendtner and Ralf Gold and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain and Scientific Reports.

In The Last Decade

Seray Demir

9 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seray Demir Germany 7 99 76 75 70 61 9 282
Laura A. Greco Italy 6 205 2.1× 98 1.3× 84 1.1× 157 2.2× 108 1.8× 8 371
Hannes Kaddatz Germany 7 49 0.5× 121 1.6× 66 0.9× 28 0.4× 55 0.9× 10 229
Sarah Joost Germany 11 76 0.8× 165 2.2× 107 1.4× 50 0.7× 113 1.9× 16 357
Lorelei C. Taylor United States 6 88 0.9× 109 1.4× 58 0.8× 44 0.6× 134 2.2× 6 283
Annemarie Woolston United Kingdom 6 55 0.6× 64 0.8× 91 1.2× 46 0.7× 43 0.7× 7 291
Akvilė Norkutė Germany 4 130 1.3× 180 2.4× 83 1.1× 43 0.6× 163 2.7× 4 342
Paula Mañá Australia 8 66 0.7× 83 1.1× 120 1.6× 23 0.3× 63 1.0× 10 375
Orla Watters Ireland 8 22 0.2× 108 1.4× 88 1.2× 43 0.6× 32 0.5× 11 248
B Dobosz Poland 7 109 1.1× 65 0.9× 82 1.1× 30 0.4× 12 0.2× 9 328
Alessandra Clodomiro Italy 9 70 0.7× 39 0.5× 76 1.0× 33 0.5× 22 0.4× 15 211

Countries citing papers authored by Seray Demir

Since Specialization
Citations

This map shows the geographic impact of Seray Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seray Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seray Demir more than expected).

Fields of papers citing papers by Seray Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seray Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seray Demir. The network helps show where Seray Demir may publish in the future.

Co-authorship network of co-authors of Seray Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Seray Demir. A scholar is included among the top collaborators of Seray Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seray Demir. Seray Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Demir, Seray, et al.. (2024). Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models. Scientific Reports. 14(1). 17823–17823. 2 indexed citations
2.
Grüter, Thomas, Seray Demir, Barbara Gisevius, et al.. (2023). Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system. Proceedings of the National Academy of Sciences. 120(4). e2216941120–e2216941120. 31 indexed citations
3.
Tietz, Silvia, Seray Demir, Robert Hoepner, et al.. (2020). Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. Journal of Neuroinflammation. 17(1). 9–9. 7 indexed citations
4.
Hoepner, Robert, Anke Salmen, Seray Demir, et al.. (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathologica. 138(3). 443–456. 39 indexed citations
5.
Demir, Seray, Kalliopi Pitarokoili, Ralf A. Linker, & Ralf Gold. (2018). Immune cell derived BDNF does not mediate neuroprotection of the murine anti-CD52 antibody in a chronic autoimmune mouse model. Journal of Neuroimmunology. 328. 78–85. 7 indexed citations
6.
Manitz, Marie Pierre, Seray Demir, Maike Ahrens, et al.. (2016). Flow cytometric characterization of microglia in the offspring of PolyI:C treated mice. Brain Research. 1636. 172–182. 19 indexed citations
7.
Demir, Seray, et al.. (2015). Low dose fumaric acid esters are effective in a mouse model of spontaneous chronic encephalomyelitis. Journal of Neuroimmunology. 285. 16–21. 7 indexed citations
8.
Duscha, Alexander, Johannes Berg, Jan Thöne, et al.. (2014). Beneficial effects of short chain fatty acids on the course of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 275(1-2). 59–59. 1 indexed citations
9.
Linker, Ralf A., Seray Demir, Stefan Wiese, et al.. (2010). Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain. 133(8). 2248–2263. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026